Free Trial
LON:STX

Shield Therapeutics (STX) Share Price, News & Analysis

Shield Therapeutics logo
GBX 2.89 +0.04 (+1.40%)
As of 07/3/2025 10:46 AM Eastern

About Shield Therapeutics Stock (LON:STX)

Key Stats

Today's Range
2.70
3
50-Day Range
2.28
3
52-Week Range
1.50
5.87
Volume
236,812 shs
Average Volume
1.99 million shs
Market Capitalization
£28.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

STX Stock News Headlines

Have you heard of “E.I.”?
Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!
Shield Therapeutics awards CEO share options
Shield Thera Regulatory News
See More Headlines

STX Stock Analysis - Frequently Asked Questions

Shield Therapeutics' stock was trading at GBX 2.70 on January 1st, 2025. Since then, STX stock has increased by 7.0% and is now trading at GBX 2.89.

Shield Therapeutics plc (LON:STX) posted its quarterly earnings results on Thursday, April, 24th. The company reported ($3.00) EPS for the quarter. Shield Therapeutics had a negative trailing twelve-month return on equity of 470.50% and a negative net margin of 173.43%.

Shares of STX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shield Therapeutics investors own include AcelRx Pharmaceuticals (ACRX), Rockwell Medical (RMTI), AstraZeneca (AZN), Model N (MODN), Cara Therapeutics (CARA), Caladrius Biosciences (CLBS) and Cellectis (CLLS).

Company Calendar

Last Earnings
4/24/2025
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Computer Hardware
Current Symbol
LON:STX
CIK
N/A
Fax
N/A
Employees
40,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
40.84
P/E Growth
N/A
Net Income
-£36.28 million
Net Margins
-173.43%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£20.92 million
Cash Flow
GBX 0.45 per share
Price / Cash Flow
6.36
Book Value
GBX 0.05 per share
Price / Book
52.81

Miscellaneous

Free Float
N/A
Market Cap
£28.52 million
Optionable
Not Optionable
Beta
1.42
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:STX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners